Vir Biotechnology
VIR
VIR
174 hedge funds and large institutions have $3.24B invested in Vir Biotechnology in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2.15% less ownership
Funds ownership: 59.16% → 57.02% (-2.1%)
11% less capital invested
Capital invested by funds: $3.64B → $3.24B (-$395M)
Holders
174
Holding in Top 10
6
Calls
$27.1M
Puts
$14.3M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$20.7M | |
| 3 | +$15.4M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$8.93M |
| 5 |
BlackRock
New York
|
+$7.75M |
Top Sellers
| 1 | -$136M | |
| 2 | -$91.4M | |
| 3 | -$22.3M | |
| 4 |
APF
Alaska Permanent Fund
Juneau,
Alaska
|
-$9.9M |
| 5 |
Morgan Stanley
New York
|
-$8.47M |